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Percutaneous ethanol injection (PEI) is an accepted 
treatment option for selected patients with hepatocel- 
lular carcinoma (HCC). PEI induces local tumor necro- 
sis as a result of protein denaturation, cellular 
dehydration, and occlusion of small vessels. PEI allows 
selective treatment of limited HCC without significant 
side effects on the adjacent liver parenchyma, nd is, 
therefore, suitable ven in advanced stages of cirrhosis 
with impaired liver function [1-3]. PEI has also been 
used to treat secondary hepatic neoplasms under certain 
circumstances, but its role and efficacy for this purpose 
remain to be defined [4]. 
Another well-established modality for treating un- 
resectable HCC is intraarterial chemoembolization. 
This is often performed with an emulsion of doxoru- 
bicin and lipiodol which accumulates preferentially 
within HCC nodules. The intraarterial technique can be 
used as a regional or segmental treatment and is partic- 
ularly suitable in the presence of daughter nodules or 
multiple HCC. To combine the advantages of intravas- 
cular segmental treatment and direct percutaneous local 
treatment of tumor nodules it has been recommended 
to use chemoembolization a d PEI sequentially [5]. 
Our current reatment protocol for unresectable HCC 
is as follows. Single nodules with a diameter <3 cm 
are treated with PEI alone. Single nodules <5 cm and 
up to three lesions <3 cm are treated with a combi- 
nation of chemoembolization a d PEI. Patients with 
nodules >5 cm or with widespread tumor disease are 
not treated with PEI but with chemoembolization alone 
or with systemic hemotherapy, or are given no treat- 
ment at all. 
The technique of PEI has been well described [1 - 
3]. The total volume of ethanol to be injected into a 
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neoplastic lesion may be determined according to the 
formula V = 4/37r (0.5 + r) 3, where V is the volume in 
milliliters, and r the radius of the lesion in centimeters. 
Treatment protocols vary in terms of volume of abso- 
lute ethanol administered per session, and in using PEI 
either alone or combined with intraarterial chemoem- 
bolization [2, 5, 6]. Although the response to PEI is 
most promising in lesions <3 cm, ablation of larger 
tumors is also feasible. 
Needle placement, monitoring of PEI, assessment 
of the treatment effect, and follow-up are done with 
cross-sectional imaging techniques. Image-guided fine- 
needle aspiration biopsy enables direct cytologic proof 
of residual or recurrent tumor, but negative sampling 
errors may easily occur in treated, partially necrotic 
lesions. Therefore, knowledge of the changes observed 
on cross-sectional images obtained uring and after PEI 
greatly facilitates diagnostic and therapeutic decisions. 
We have used PEI with ultrasound (US) and com- 
puted tomography (CT) guidance, either alone or in 
combination with chemoembolization, i  35 patients; 
32 of these had histologically proven HCC and 3 had 
secondary lesions of gastrointestinal neoplasms. We 
describe the immediate, early, and late changes ob- 
served on US, CT, and magnetic resonance (MR) im- 
ages after PEI treatment. 
Monitoring of PEI 
PEI may be done with US guidance whenever the le- 
sion to be treated is sufficiently well visualized. In ad- 
dition to its low cost and availability, US monitoring 
offers the advantage of visualizing the distribution of 
ethanol directly because microbubbles injected with the 
ethanol are hyperechogenic (Fig. 1). However, when 
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Fig. 1. US-guided percutaneous ethanol injection (PEI) of hepatocellular carcinoma 
(HCC) and follow-up with CT. A Contrast enhanced CT scan (venous phase) shows a 
hypoattenuating mass 5 cm in diameter within the right hepatic lobe corresponding to a 
single HCC nodule. B On US, the mass is hyperechogenic and well defined. A special 
21 gauge needle with multiple side holes but no end hole (Ago Pia, Milan, Italy), has 
been inserted under US guidance; the position of the needle tip close to the posterior 
border of the lesion (arrow) indicates that e side holes are in an appropriate position. 
C Injection of ethanol causes echogenic artifacts within the lesion and acoustic shadowing 
due to microbubbles, thus allowing real-time onitoring of the distribution of ethanol. 
D After injection of 20 ml of ethanol, the lesion becomes obscured by these artifacts. 
E Contrast enhanced spiral CT (venous phase) obtained 24hr later demonstrates the ef- 
fect of PEI. The smooth, regular, enhancing rim around the nonenhancing tumor persist- 
ing in the venous phase was interpreted as reactive hyperemia r ther than residual tumor. 
No further treatment was given. There was no evidence of residual tumor or local tumor 
recurrence on follow-up. 
Fig. 2. CT-guided PEI of large HCC. HCC lesion 5 cm in diameter was treated with a total volume of 170 ml of absolute thanol administered 
in six PEI sessions. The distribution of ethanol is well visualized because it is hypoattenuafing compared with tumor andliver tissue. Note that 
some ethanol is visible in the liver tissue adjacent to the tumor (arrow). 
Fig. 3. Periportal tracking of ethanol during CT-guided PEI of a recurrent HCC nodule in the left hepatic lobe after fight hepatectomy. 
Hypoattenuating ethanol is not only seen within the treated lesion but also follows a linear track along the portal system of the left hepatic 
lobe (arrowheads). 
large vo lumes o f  ethanol  are injected, the lesion even-  
tually becomes  obscured by acoustic shadowing and 
reverberat ion artifacts (Fig. 1D). CT  guidance is pre- 
ferred for PEI  whenever  US  does not permit  suff icient 
v isual izat ion of  the lesion to enable the needle to be 
p laced correctly,  part icularly in large tumors that often 
require mult ip le PEI  sessions (Fig. 2). Contrast-en- 
hanced dynamic  CT  and, especial ly,  spiral CT  is su- 
perior to US  for v isual iz ing the extent o f  necrosis 
induced by PEI.  PE I - induced necrosis results in a lack 
of  enhancement,  and the hypodense,  necrot ic areas are 
wel l  del ineated on CT, usual ly with attenuation values 
of  30 -35  HU (Fig. 1E). In jected ethanol  may be vi-  
sual ized on CT  as it is hypoattenuat ing compared with 
tumor and l iver  t issue and even more hypoattenuat ing 
than necrosis (<200 HU)  (Fig. 2). Extratumoral  track- 
ing of  ethanol  is seen after inject ion of  large vo lumes  
and usual ly occurs a long the portal triad (Fig. 3). I fPE I  
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Fig. 4. Combined treatment of HCC with chemoembolization and 
PEI: immediate CT findings. A Contrast-enhanced spiral CT shows 
a HCC with a diameter of 3cm before treatment with chemoembol- 
ization with doxorubicin and iodized oil. B Unenhanced scan ob- 
tained 4 weeks after selective intraarterial chemoembolization and 
immediately before PEI. The lesion is hyperattenuating due to reten- 
tion of iodized oil. C Unenhanced scan obtained immediately after 
PEI. A mixed-density pattern is seen owing to the hypoattenuating 
ethanol. D Early follow-up. Contrast-enhanced spiral CT scan ob- 
tained for follow-up several days after PEI. The hypoattenuating 
areas have disappeared, but some residual hyperattenuating areas due 
to iodized oil are still visible. E, F Follow-up study obtained 10 
month  after treatment because of rising alpha-fetoprotein levels. 
Dual-phase spiral CT, same study. E Arterial phase. The treated le- 
sion within the right lobe shows no enhancement (large arrows). 
Some residual hyperattenuating lipiodol is visible within the lesion. 
However, there are now multiple hyperattenuating lesions visible 
mainly throughout the left hepatic lobe (small arrows). F Venous 
phase. The treated lesion shows no enhancement (large arrows). The 
small nodules are less well visualized than in the arterial phase b - 
c use they have become almost isoattenuating or slightly hypoatten- 
uating with the surrounding liver parenchyma (small arrows). 
is done after chemoembolizat ion, a mixed-density pat- 
tern may be observed ue to hyperattenuating, retained, 
iodized oil and hypoattenuating ethanol (Fig. 4). Tu- 
mors that are well defined, such as HCC with a capsule, 
are well suited for PEI because the ethanol distributes 
relatively homogeneously within the lesion (Figs. l ,  2, 
4, 5). PEI of poorly defined, infiltrating tumors is more 
difficult to control (Fig. 6). 
Ear ly  Follow-up After PEI  
Fol low-up studies at defined intervals are necessary in 
order to evaluate the effect of  PEI and to detect resid- 
ual, recurrent, or new tumor manifestations. Routine 
controls should include biochemical tumor markers, 
such as alpha-fetoprotein levels, and image-guided bi- 
opsies. However, tumor markers may fail to be elevated 
before PEI, and cytologic examination may be false 
negative after PEI in a considerable number of cases. 
Therefore, the findings on diagnostic imaging studies 
must also be taken into consideration. 
Contrast-enhanced, dynamic, incremental or spiral 
CT is currently the most common imaging technique 
for fol low-up after PEI. The typical behavior of HCC 
nodules on CT is hyperattenuation compared with the 
surrounding liver parenchyma in the arterial phase, of- 
ten fol lowed by hypoattenuation in the venous phase. 
Therefore, CT is best performed in the form of dual- 
phase spiral CT with an arterial and venous phase (Fig. 
4E, F). CT studies of large tumors obtained within 24-  
48 hr after PEI may show small gas collections. Al- 
though these are often due to small injected air bubbles, 
gas formation may also occur due to tissue necrosis [6]. 
As with arterial embolization, these changes usually 
disappear spontaneously and should not be mistaken 
for abscess formation. Several investigators have 
shown that circumscribed, nodular enhancement in the 
area of the treated lesion is a rel iable indicator of re- 
sidual tumor [6-8]  (Figs. 5B, 6B). Occasionally, 
smooth, regular, peripheral enhancement may be seen 
corresponding to reactive hyperemia (Fig. 1E). Ebara 
et al. [8] have shown that residual tumor shows en- 
hancement in the early but not in the late phase, 
Fig. 5. Encapsulated HCC treated with PEI 
alone: early follow-up with CT. A Contrast- 
enhanced spiral CT shows a HCC lesion with 
an enhancing capsule before treatment with 40 
ml of ethanol under US guidance in one ses- 
sion. B On the contrast-enhanced spiral CT 
image the treated lesion remains unenhanced, 
but a small nodular area of enhancement is 
seen close to the capsule, corresponding to vi- 
able tumor (arrow). 
Fig. 6. Infiltrating HCC treated with PEI alone: findings on contrast-enhanced spiral CT. A A hypervascular HCC is seen in the left lobe 
(segment 4) of a cirrhotic liver. The lesion is poorly defined against the surrounding parenchyma. B One day after PEI, a large hypoattenuating 
area is seen in segment 4, indicating necrosis. The enhancing area (arrows) corresponded to residual viable tumor on fine-needle aspiration 
biopsy and additional treatment was needed. C Six months later, the area of necrosis has decreased in size, indicating local tumor control. 
However, a small secondary lesion has appeared in the fight lobe (arrow). 
Fig. 7. Small HCC treated with PEI and chemoembolizafion: MR findings. A Before txeatment. On the unenhanced Tl-weighted SE image a hyperintense 
nodule of 2 cm is seen in the fight hepatic lobe, which corresponded to an HCC nodule. B Early findings after PEI, On the unenhanced Tl-weighted SE 
image obtained after chemcembofization with doxorubicin and iodized oil and PEI, the hyperintense area has become much larger, probably due to 
hemorrhage. C On the corresponding T2-weighted FSE image (with fat saturation), the lesion is hyperintense. This could be due to hemorrhage or
fiquefactive necrosis o1" residual viable tumor. D On the gadolinium-DTPA-enhanced Tl-weighted SE image the center of the lesion lacks enhancement, 
but there is intense nhancement at he periphery. These findings indicate that the center of the lesion has become necrotic but that residual viable tumor 
may be present at the periphery. E Follow-up 3 months ",ffter additional PEI. T2-weighted FSE image at the same level as C shows a lack of signal wifffin 
the tumor. The lesion is almost isointense compared with the surrounding parenchyma. These findings indicate coagulative necrosis. 
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Fig. 8. Chemical portal vein thrombus following US-guided PEI. Patency of the portal vein had been documented before US-guided PEI in 
this patient with a HCC in segment 4, adjacent to the left portal vein. The axial US image A and the sagittal image B were obtained 24hr after 
PEI and show the tumor (73, and a solid thrombus in the left portal branch adjacent to the tumor (arrows). C, D These contrast-enhanced spiral 
CT images were obtained 6 days after US-guided PEI, and confirm the presence of a solid floating thrombus in the left main portal branch 
(arrows). E -G  Contrast-enhanced spiral CT was repeated 4 months later. At this time, the tumor has decreased in size E, and the thrombus 
has disappeared (F, G). 
whereas reactive inflammation shows enhancement i  
both the early and the late phase. 
Investigation of the MR imaging findings after PEI 
has mainly been focused on HCC [9-15]. Although the 
spatial resolution of MR images is currently still infe- 
rior to that of CT images and T2-weighted images often 
suffer from motion artifacts, ithas been shown that MR 
may be used as an alternative to CT to evaluate the 
effect of PEI. The signal changes observed on MR im- 
ages after PEI are somewhat more complex than the 
changes observed on CT scans. The MR imaging ap- 
pearance of untreated HCC is variable. This may be 
attributable to several factors, including magnetic field 
strength, tumor size, histologic tumor grade, presence 
of a capsule, and fatty or hemorrhagic intratumoral 
changes. On unenhanced Tl-weighted images, HCC 
may be hyperintense (Fig. 7A), hypointense, or isoin- 
tense relative to surrounding liver tissue. There is no 
uniform behavior after intravenous injection of gado- 
linium chelates, although most lesions show at least 
some enhancement [9-11]. On unenhanced, T2- 
weighted images, over 80% of HCC are moderately to
strongly hyperintense, but a significant minority is iso- 
or hypointense [9, 12, 13]. The MR signal changes of 
HCC induced by PEI with and without concomitant 
chemoembolization have been analyzed in several 
studies. The signal patterns on unenhanced T1- 
weighted images are variable and nonspecific [9, 14]. 
An increased signal intensity within or around the le- 
sion may be observed in the early phase after PEI and 
can be xplained by hemorrhage (Fig. 7B). High-signal 
areas on T2-weighted images may correspond with 
hemorrhage or liquefactive n crosis or reactive inflam- 
mation but also with residual viable tumor (Fig. 7C) 
[11, 15]. However, a homogeneously h pointense sig- 
nal of a previously hyperintense tumor on a T2- 
weighted sequence seems to correlate with coagulative 
necrosis (Fig. 7E). In cases of doubt, Tl-weighted im- 
ages obtained after intravenous administration of gad- 
olinium chelates may be used to distinguish viable 
tumor from liquefactive necrosis, since tumor shows 
enhancement and necrosis does not [15] (Fig. 7D). Al- 
though the necrotizing effects of PE1 and of chemoem- 
bolization with iodized oil are different, the effects 
observed on MR images after the combination of these 
two modalities are the same as with PEI alone. Barto- 
lozzi et al. [14] have shown that retention of iodized 
oil after chemoembolization does not interfere with the 
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Fig. 9. Long-term follow-up after PEI of a small HCC in a noncirrhotic liver. A Contrast-enhanced spiral CT image shows a 3-cm HCC in the 
right lobe of a noncirrhotic liver (arrowhead). The tumor became manifest due to massive subcapsular hemorrhage (arrows) and a biopsy was 
done after spontaneous resolution f the hematoma. The serum alpha-fetoprotein level was significantly elevated. B Contrast-enhanced spiral 
CT image obtained immediately after PEI. Some densely hyperattenuating areas within the lesion are due to previous angiography with injection 
of iodized oil. Note the residual subcapsular hematoma. After three sessions of PEI, the alpha-fetoprotein levels became normal and remained 
so during further follow-up. C, D Contrast-enhanced spiral CT images show the lesion 7 months and 2.5 years after PEI; there was no evidence 
of tumor growth. 
Fig. 10. Needle-tract seeding after PEI of HCC. Contrast-enhanced spiral CT image obtained 8 months after six PEI treatment sessions of he 
large HCC shown i  Figure 2. At the previous puncture sites there is diffuse perihepatic infiltration corresponding with needle-tract seeding 
(arrows). Intrahepatically, there are multiple areas of nodul r enhancement at the periphery of the treated lesion, consistent with recurrent 
tumor growth (arrowheads). However, biopsyof the second enhancing nodule adjacent to th  gallbladder (asterisk) revealed no malignant 
cells. 
MR signal pattern. This may in fact be an advantage of 
MR imaging compared with CT, on which retained io- 
dized oil alters the attenuation values considerably 
(Figs. 4, 9). It is l ikely that the recent technical d- 
vances in the field of MRI,  such as fast and "ultra- 
fast"  sequences, wil l  improve the quality of  
T2-weighted images as motion artifacts due to respi- 
ration can be reduced. 
Gray-scale US cannot rel iably delineate residual 
viable tumor tissue. Color Doppler US has been rec- 
ommended for assessing the effect of PEI treatment 
[16]. In our experience, however, only a minority of 
HCC showed an adequate color flow signal due to hy- 
pervascularity that would have enabled us to detect 
small residual foci of viable tumor. Power Doppler 
may enhance the abil ity of US to detect small 
tumor foci with moderate vascularity. The role of 
[18F] f luorodeoxyglucose pos i t ron-emiss ion  tomo-  
graphic imaging remains to be determined [17]. Selec- 
tive arteriography has been used in early studies [ 1 ] but 
appears too invasive for serial fol low-up tests after PEI 
unless performed in the course of complementary 
chemoembolizat ion. If doubt persists regarding resid- 
ual malignant issue, percutaneous fine-needle aspira- 
tion biopsy should always be performed. 
Complications 
Side effects of  PEI  inc lude transient  local  pain and 
fever, espec ia l ly  after in ject ion of  large vo lumes of  
ethanol .  PEI  is a safe t reatment and serious, 
procedure-related complications are rare [ 18]. As with 
percutaneous fine-needle puncture in general, pneu- 
mothorax and hemorrhage are potential but rare com- 
plications. Superinfection of  necrotic tumor tissue is 
theoretically possible but has not been found to be a 
significant concern after PEI. Due to its severe throm- 
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bogenic effect, ethanol may occasionally induce a por- 
tal vein thrombus. Such "chemical"  thrombi become 
visible immediately after PEI (Fig. 8). They are usually 
reversible and should not be confused with tumor 
thrombus [3]. 
Long-term Follow-up 
PEI, if performed in limited HCC, enables effective 
tumor destruction and control of local tumor growth 
(Fig. 9). The results of recent long-term studies uggest 
that the overall survival rates after PEI treatment are 
comparable to those after surgical resection, mainly de- 
pending on tumor size and Child's stage of cirrhosis 
[1-3,  8, 18]. Early observations have suggested that 
PEI combined with chemoembolization is even more 
effective than PEI alone [5]. Recurrent manifestations 
of HCC after PEI may occur locally or in the form of 
single or multiple intrahepatic secondary lesions (Figs. 
4E, F and 6). Needle-tract seeding is an uncommon 
phenomenon but has been observed after PEI treatment 
of both HCC and liver metastases [19-21] (Fig. 10). 
Summary 
Since PEI is a treatment based on imaging techniques, 
the radiologist should be familiar with the various find- 
ings that may be observed after PEI on US, CT, and 
MR images immediately after treatment and during 
later follow-up, Although US is well suited for per- 
forming PEI, contrast-enhanced CT currently is the 
most commonly used imaging method to evaluate the 
effect of PEI. Residual, nodular areas of contrast en- 
hancement correlate well with residual tumor and war- 
rant additional treatment. Although the findings on MR 
images obtained after PEI are more complex, MR im- 
aging may be used as an alternative to CT. 
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